Search

A recent study conducted at the University of Michigan evaluated the feasibility and performance of continuous glucose monitoring (CGM) to guide computerized insulin infusion therapy in the cardiovascular intensive care unit. The study found that CGM, when combined with periodic point-of-care blood glucose tests, was accurate and convenient for both nurses and patients. The results suggest that adopting CGM in postoperative care could improve workflow, enhance health outcomes, and be cost-effective. Further research is needed to confirm these findings. [Extracted from the article]

Medtronic Inc. has been issued a patent for a self-calibrating glucose monitor. The patent describes a medical system that uses machine learning algorithms to determine a representative glucose level in a patient based on a current cardiac signal. The system includes sensing circuitry to sense a cardiac characteristic and a glucose sensor to determine the glucose level. The processing circuitry formulates training data sets using the cardiac signal and glucose signal, trains the machine learning algorithm, and determines the representative glucose level. The system may also include a portable device to support the glucose sensor, sensing circuitry, and processing circuitry. This patent provides a potential advancement in glucose monitoring technology for diabetes patients. [Extracted from the article]

Keywords: Cardiac Surgery; Cardiology; Cardiovascular Diabetology; Health and Medicine EN Cardiac Surgery Cardiology Cardiovascular Diabetology Health and Medicine 872 872 1 09/11/23 20230911 NES 230911 2023 SEP 11 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Researchers detail new data in cardiovascular diabetology. Keywords for this news article include: University of Franche-Comte, Cardiology, Cardiac Surgery, Health and Medicine, Cardiovascular Diabetology. [Extracted from the article]

Business, Cardiology, Cerebrovascular Diseases and Conditions, DEKA Products Limited Partnership, Glucose Metabolism Disorders, Health and Medicine, Heart Attack, Heart Disorders and Diseases, Hyperglycemia, Hypoglycemia, Metabolic Diseases and Conditions, Nutritional and Metabolic Diseases and Conditions, Peptide Hormones, Peptide Proteins, Proinsulin, Risk and Prevention, Stroke Patent URL (for desktop use only): https://ppubs.uspto.gov/pubwebapp/external.html?q=(11707567)&db=USPAT&type=ids Keywords for this news article include: Stroke, Business, Cardiology, Proinsulin, Heart Attack, Hypoglycemia, Hyperglycemia, Peptide Hormones, Peptide Proteins, Health and Medicine, Risk and Prevention, Glucose Metabolism Disorders, Heart Disorders and Diseases, DEKA Products Limited Partnership, Cerebrovascular Diseases and Conditions. [Extracted from the article]